Agilon Health, Inc. (AGL)
115.66
+5.36
(+4.86%)
USD |
NYSE |
Nov 13, 16:00
115.65
-0.01
(-0.01%)
After-Hours: 19:59
Agilon Health EPS Diluted (Quarterly) : 1.974 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.974 |
| June 30, 2026 | 1.043 |
| March 31, 2026 | 1.796 |
| December 31, 2025 | -11.39 |
| September 30, 2025 | -6.648 |
| June 30, 2025 | -6.305 |
| March 31, 2025 | -0.0046 |
| December 31, 2024 | -6.418 |
| September 30, 2024 | -0.2829 |
| June 30, 2024 | -0.0746 |
| March 31, 2024 | -0.0148 |
| December 31, 2023 | -0.4499 |
| September 30, 2023 | -1.937 |
| June 30, 2023 | -1.020 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.9695 |
| December 31, 2022 | -3.426 |
| September 30, 2022 | -0.074 |
| June 30, 2022 | -0.0507 |
| March 31, 2022 | 0.0029 |
| December 31, 2021 | -0.1418 |
| September 30, 2021 | -0.0915 |
| June 30, 2021 | -0.7645 |
| March 31, 2021 | -0.0386 |
| December 31, 2020 | -0.1142 |
| September 30, 2020 | -0.0303 |
| June 30, 2020 | -0.0202 |
| March 31, 2020 | -0.0412 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Astrana Health, Inc. | 0.2595 |
| Starling Oncology, Inc. | -0.1269 |
| Nakamoto, Inc. | 4.068 |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | -0.7535 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 34.91M |
| Revenue (Quarterly) | 1.519B |
| Total Expenses (Quarterly) | 1.485B |
| Enterprise Value | 1.664B |
| Gross Profit Margin (Quarterly) | 6.00% |
| Profit Margin (Quarterly) | 2.30% |
| Earnings Yield | -5.69% |
| Normalized Earnings Yield | -3.721 |